Indegene Limited is an India-based tech-native, life sciences commercialization company. The Company provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech, and medical devices companies. Its segments include Enterprise Medical Solutions, Enterprise Commercial Solutions, Brand Activation, and Others. The Enterprise Commercial Solutions business unit caters to the digital marketing operations of life sciences companies. The Enterprise Medical Solutions consolidates large-scale regulatory and medical operations for life sciences companies. The Brand Activation segment offers promotion of biopharmaceutical products and medical devices to HCPs for life sciences companies across channels. It provides customized marketing campaigns through a comprehensive portfolio of proprietary program offerings. Others mainly consist of consultancy and clinical business.As of 25 May 2026, INDEGENE LIMITED share price is ₹517.90. The stock opened at ₹509.05, compared to its previous close of ₹508.55. During today's trading session, INDEGENE LIMITED share price moved in the range of ₹509.05 to ₹525.65, with an average price of ₹517.35 for the day. Looking at its last 52-week, the stock has touched a low of ₹509.05 and a high of ₹525.65. On the performance front, INDEGENE LIMITED share price has increased by 0.26% over the last six months and is down 13.91% on a year-on-year basis.
The market capitalization of INDEGENE LIMITED is ₹12,239 Crs, with a P/E ratio of 30.5 and a dividend yield of 0.44%.